These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 23599251)

  • 21. Suicide, attempted suicide, and relapse rates in depression.
    Avery D; Winokur G
    Arch Gen Psychiatry; 1978 Jun; 35(6):749-53. PubMed ID: 655772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Continuation ECT].
    Sartorius A; Henn FA
    Psychiatr Prax; 2005 Nov; 32(8):408-11. PubMed ID: 16308805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Delusional depression].
    Watanabe Y; Matsubara T
    Nihon Rinsho; 2001 Aug; 59(8):1546-9. PubMed ID: 11519156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to managing psychotic depression.
    Schatzberg AF
    J Clin Psychiatry; 2003; 64 Suppl 1():19-23. PubMed ID: 12625801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review and meta-analysis of maintenance treatment for psychotic depression.
    Al-Wandi A; Holmberg C; Landén M; Nordenskjöld A
    Nord J Psychiatry; 2022 Aug; 76(6):442-450. PubMed ID: 34665684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.
    Blumberger DM; Mulsant BH; Emeremni C; Houck P; Andreescu C; Mazumdar S; Whyte E; Rothschild AJ; Flint AJ; Meyers BS
    J Psychiatr Res; 2011 Jul; 45(7):896-901. PubMed ID: 21300377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P300 changes in major depressive disorders with and without psychotic features.
    Karaaslan F; Gonul AS; Oguz A; Erdinc E; Esel E
    J Affect Disord; 2003 Feb; 73(3):283-7. PubMed ID: 12547298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features.
    Andreescu C; Mulsant BH; Peasley-Miklus C; Rothschild AJ; Flint AJ; Heo M; Caswell M; Whyte EM; Meyers BS;
    J Clin Psychiatry; 2007 Feb; 68(2):194-200. PubMed ID: 17335316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression.
    Hamoda HM; Osser DN
    Harv Rev Psychiatry; 2008; 16(4):235-47. PubMed ID: 18661366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How long should patients with psychotic depression stay on the antipsychotic medication?
    Rothschild AJ; Duval SE
    J Clin Psychiatry; 2003 Apr; 64(4):390-6. PubMed ID: 12716238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
    Verdolini N; Hidalgo-Mazzei D; Murru A; Pacchiarotti I; Samalin L; Young AH; Vieta E; Carvalho AF
    Acta Psychiatr Scand; 2018 Sep; 138(3):196-222. PubMed ID: 29756288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic correlates of antidepressant and antipsychotic response in patients with psychotic depression undergoing electroconvulsive therapy.
    McCormick LM; Boles Ponto LL; Pierson RK; Johnson HJ; Magnotta V; Brumm MC
    J ECT; 2007 Dec; 23(4):265-73. PubMed ID: 18090701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychotic major depression: a benefit-risk assessment of treatment options.
    Tyrka AR; Price LH; Mello MF; Mello AF; Carpenter LL
    Drug Saf; 2006; 29(6):491-508. PubMed ID: 16752932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuation ECT: relapse prevention in affective disorders.
    Petrides G; Dhossche D; Fink M; Francis A
    Convuls Ther; 1994 Sep; 10(3):189-94. PubMed ID: 7834255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy Prescriptions for Relapse Prevention of Psychotic Depression After Electroconvulsive Therapy.
    Patel DA; Flint AJ; Rothschild AJ; Whyte EM; Meyers BS; Mulsant BH; Voineskos AN; Marino P; Alexopoulos GS;
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):196-199. PubMed ID: 33587400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The definition and meaning of treatment-resistant depression.
    Sackeim HA
    J Clin Psychiatry; 2001; 62 Suppl 16():10-7. PubMed ID: 11480879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor gamma co-activator-1 alpha in depression and the response to electroconvulsive therapy.
    Ryan KM; Patterson I; McLoughlin DM
    Psychol Med; 2019 Aug; 49(11):1859-1868. PubMed ID: 30191781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance electroconvulsive therapy in affective and schizoaffective disorder.
    Swoboda E; Conca A; König P; Waanders R; Hansen M
    Neuropsychobiology; 2001 Jan; 43(1):23-8. PubMed ID: 11150895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotics in the maintenance phase for psychotic depression.
    Al-Wandi A; Landén M; Nordenskjöld A
    Acta Psychiatr Scand; 2024 Jan; 149(1):6-17. PubMed ID: 37932158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-episode psychosis: an epidemiological survey comparing psychotic depression with schizophrenia.
    Crebbin K; Mitford E; Paxton R; Turkington D
    J Affect Disord; 2008 Jan; 105(1-3):117-24. PubMed ID: 17574683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.